XML 23 R12.htm IDEA: XBRL DOCUMENT v3.20.1
LONG-TERM DEBT
9 Months Ended
Mar. 28, 2020
Debt Disclosure [Abstract]  
LONG-TERM DEBT
Long-Term Debt
On March 5, 2020, the Company entered into a Seventh amendment to the amended and restated credit agreement extending the limit on our line of credit facility to $65.0 million. Outside of the limit increase of the credit facility, the agreement reflects the same specifications and terms as the sixth amendment to the amended and restated credit agreement entered into by the Company on November 20, 2019; discussed below. As of March 28, 2020, the Company had an outstanding balance under the credit facility of $57.2 million, $0.4 million in outstanding letters of credit and $7.4 million available for future borrowings. As of June 29, 2019, the Company had an outstanding balance under the credit facility of $23.4 million, $0.4 million in outstanding letters of credit and $21.3 million available for future borrowings.
On November 20, 2019, the Company entered into a Sixth amendment to the amended and restated credit agreement extending the limit on our line of credit facility to $55.0 million as evidenced by the Second Replacement Revolving Note. The agreement specifies that the proceeds of the revolving line of credit be used primarily for working capital and general corporate purposes. The line of credit is secured by substantially all of the assets of the Company. On September 30, 2018, the Company entered into a Fourth amendment to the amended and restated credit agreement to extend the maturity date to November 1, 2023, at which time all outstanding balances are payable.
On September 10, 2019, the Company entered into a Fifth amendment to the amended and restated credit agreement to increase the outstanding balance on the term loan in the amount of $5.0 million and to extend the maturity date to September 30, 2022 on the original term loan in the amount of $35.0 million that was used to acquire all of the outstanding shares of CDR Manufacturing, Inc. (dba Ayrshire Electronics). The term loan requires quarterly payments of $1.67 million commencing December 31, 2019 through September 30, 2021, and quarterly payments of $0.4 million commencing December 31, 2021 through September 30, 2022, with a final payment of the remaining outstanding balance on September 30, 2022. The Company had an outstanding balance of $11.7 million and $11.3 million under the term loan as of March 28, 2020 and June 29, 2019, respectively.
On December 28, 2016, the Company entered into an equipment term loan agreement in the amount of $3.9 million in order to further invest in production equipment. The equipment term loan is collateralized by production equipment. Under this loan agreement, equal quarterly payments of approximately $0.2 million commenced on March 31, 2017 and will continue through the maturity of the equipment term loan on June 30, 2021. Amortization of the debt issuance costs is reported as interest expense on the consolidated income statement. As of March 28, 2020, the Company had an outstanding balance of $1.1 million. As of June 29, 2019, the Company had an outstanding balance of $1.7 million.
The Fifth amendment to the amended and restated credit agreement noted above to increase the outstanding balance on the term loan in the amount of $5.0 million fixes borrowings under the revolving line of credit, term loan and equipment term loan to bear interest at LIBOR plus 2.0%, as opposed to previous borrowings at either a “Base Rate” or a “Fixed Rate,” as elected by the Company. The base rate is the higher of the Wells Fargo Bank prime rate, daily one month London Interbank Offered Rate (LIBOR) plus 1.5%, or the Federal Funds rate plus 1.5%. The fixed rate is LIBOR plus 1.75%, LIBOR plus 2.00%, or LIBOR plus 2.25% depending on the level of the Company’s trailing four quarters Earnings Before Interest, Taxes, Depreciation and Amortization (EBITDA). The interest rates on outstanding debt as of March 28, 2020 range from 2.99% - 3.58% compared to 4.40% - 5.50% as of June 29, 2019.
Debt maturities as of March 28, 2020 for the next five years and thereafter are as follows (in thousands):
Fiscal Years Ending
Amount
2020 (1)
$
1,884

2021
7,537

2022
2,917

2023
417

2024
57,236

Total debt
$
69,991

Unamortized debt issuance costs
(37
)
Long-term debt, net of debt issuance costs
$
69,954

(1) Represents scheduled payments for the remaining three-month period ending June 27, 2020.
The Company must comply with certain financial covenants, including a fixed charge coverage ratio. The credit agreement requires the Company to maintain a minimum profit threshold, limits the maximum capital lease expenditures and restricts the Company from declaring or paying dividends in cash or stock without prior bank approval. The Company was in compliance with all financial covenants as of March 28, 2020.